Xylinas, E.; Hassler, M.R.; Zhuang, D.; Krzywinski, M.; Erdem, Z.; Robinson, B.D.; Elemento, O.; Clozel, T.; Shariat, S.F.
An Epigenomic Approach to Improving Response to Neoadjuvant Cisplatin Chemotherapy in Bladder Cancer. Biomolecules 2016, 6, 37.
https://doi.org/10.3390/biom6030037
AMA Style
Xylinas E, Hassler MR, Zhuang D, Krzywinski M, Erdem Z, Robinson BD, Elemento O, Clozel T, Shariat SF.
An Epigenomic Approach to Improving Response to Neoadjuvant Cisplatin Chemotherapy in Bladder Cancer. Biomolecules. 2016; 6(3):37.
https://doi.org/10.3390/biom6030037
Chicago/Turabian Style
Xylinas, Evanguelos, Melanie R. Hassler, Dazhong Zhuang, Martin Krzywinski, Zeynep Erdem, Brian D. Robinson, Olivier Elemento, Thomas Clozel, and Shahrokh F. Shariat.
2016. "An Epigenomic Approach to Improving Response to Neoadjuvant Cisplatin Chemotherapy in Bladder Cancer" Biomolecules 6, no. 3: 37.
https://doi.org/10.3390/biom6030037
APA Style
Xylinas, E., Hassler, M. R., Zhuang, D., Krzywinski, M., Erdem, Z., Robinson, B. D., Elemento, O., Clozel, T., & Shariat, S. F.
(2016). An Epigenomic Approach to Improving Response to Neoadjuvant Cisplatin Chemotherapy in Bladder Cancer. Biomolecules, 6(3), 37.
https://doi.org/10.3390/biom6030037